Advertisement
QGEN or SINT or STIM
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
QGEN’s FA Score shows that 1 FA rating(s) are green whileSINT’s FA Score has 1 green FA rating(s), and STIM’s FA Score reflects 0 green FA rating(s).
- QGEN’s FA Score: 1 green, 4 red.
- SINT’s FA Score: 1 green, 4 red.
- STIM’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
QGEN’s TA Score shows that 4 TA indicator(s) are bullish while SINT’s TA Score has 6 bullish TA indicator(s), and STIM’s TA Score reflects 4 bullish TA indicator(s).
- QGEN’s TA Score: 4 bullish, 6 bearish.
- SINT’s TA Score: 6 bullish, 4 bearish.
- STIM’s TA Score: 4 bullish, 6 bearish.
Price Growth
QGEN (@Medical Specialties) experienced а +2.26% price change this week, while SINT (@Medical/Nursing Services) price change was +32.77% , and STIM (@Medical/Nursing Services) price fluctuated -3.00% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +8.25%, and the average quarterly price growth was +13.64%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.04%. For the same industry, the average monthly price growth was +4.21%, and the average quarterly price growth was +24.44%.
Reported Earning Dates
QGEN is expected to report earnings on Nov 04, 2025.
STIM is expected to report earnings on Nov 11, 2025.
Industries' Descriptions
@Medical Specialties (+1.01% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-0.04% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| QGEN | SINT | STIM | |
| Capitalization | 10.3B | 15.2M | 214M |
| EBITDA | 715M | -11.59M | -39.31M |
| Gain YTD | 10.437 | 57.429 | 100.621 |
| P/E Ratio | 28.13 | N/A | N/A |
| Revenue | 2.04B | 950K | 111M |
| Total Cash | 954M | 4.32M | 11.1M |
| Total Debt | 1.44B | 3.53M | 80.7M |
QGEN | SINT | STIM | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 66 | 50 | 60 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 31 Undervalued | 56 Fair valued | 40 Fair valued | |
PROFIT vs RISK RATING 1..100 | 85 | 100 | 100 | |
SMR RATING 1..100 | 68 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 51 | 35 | 42 | |
P/E GROWTH RATING 1..100 | 99 | 4 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 75 | 20 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
QGEN's Valuation (31) in the Medical Specialties industry is in the same range as STIM (40) and is in the same range as SINT (56). This means that QGEN's stock grew similarly to STIM’s and similarly to SINT’s over the last 12 months.
QGEN's Profit vs Risk Rating (85) in the Medical Specialties industry is in the same range as STIM (100) and is in the same range as SINT (100). This means that QGEN's stock grew similarly to STIM’s and similarly to SINT’s over the last 12 months.
QGEN's SMR Rating (68) in the Medical Specialties industry is in the same range as STIM (100) and is in the same range as SINT (100). This means that QGEN's stock grew similarly to STIM’s and similarly to SINT’s over the last 12 months.
SINT's Price Growth Rating (35) in the Medical Specialties industry is in the same range as STIM (42) and is in the same range as QGEN (51). This means that SINT's stock grew similarly to STIM’s and similarly to QGEN’s over the last 12 months.
SINT's P/E Growth Rating (4) in the Medical Specialties industry is significantly better than the same rating for QGEN (99) and is significantly better than the same rating for STIM (100). This means that SINT's stock grew significantly faster than QGEN’s and significantly faster than STIM’s over the last 12 months.
| QGEN | SINT | STIM | |
|---|---|---|---|
| RSI ODDS (%) | 3 days ago 68% | 3 days ago 90% | 3 days ago 80% |
| Stochastic ODDS (%) | 3 days ago 52% | 3 days ago 90% | 3 days ago 68% |
| Momentum ODDS (%) | 3 days ago 57% | 3 days ago 87% | 3 days ago 87% |
| MACD ODDS (%) | 5 days ago 59% | 3 days ago 90% | 3 days ago 90% |
| TrendWeek ODDS (%) | 3 days ago 56% | 3 days ago 80% | 3 days ago 88% |
| TrendMonth ODDS (%) | 3 days ago 53% | 3 days ago 80% | 3 days ago 90% |
| Advances ODDS (%) | 3 days ago 57% | 5 days ago 84% | 4 days ago 85% |
| Declines ODDS (%) | 11 days ago 50% | 24 days ago 90% | 6 days ago 90% |
| BollingerBands ODDS (%) | 3 days ago 61% | 3 days ago 90% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 46% | 3 days ago 78% | 3 days ago 90% |
Advertisement
QGEN and
Correlation & Price change
A.I.dvisor indicates that over the last year, QGEN has been loosely correlated with DHR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if QGEN jumps, then DHR could also see price increases.
| Ticker / NAME | Correlation To QGEN | 1D Price Change % | ||
|---|---|---|---|---|
| QGEN | 100% | +1.08% | ||
| DHR - QGEN | 66% Loosely correlated | +0.59% | ||
| RVTY - QGEN | 61% Loosely correlated | +1.10% | ||
| TMO - QGEN | 59% Loosely correlated | +0.64% | ||
| A - QGEN | 59% Loosely correlated | +0.21% | ||
| MTD - QGEN | 58% Loosely correlated | +1.39% | ||
More | ||||